MP Materials (NYSE:MP) Announces Partnership With U.S. Department of Defense
Be aware that MP Materials is showing 1 weakness in our investment analysis.
The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 23 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
The recent partnership between MP Materials and the U.S. Department of Defense is poised to enhance the domestic rare earth magnet supply chain, potentially bolstering both revenue and earnings forecasts. By securing a foothold in critical supply chains, the company is likely to see increased production and revenue growth in ex-China markets. This alignment with governmental initiatives could provide further impetus for their ambitious revenue growth targets and earnings turnaround. As management pushes forward with efficiency-driven projects, any further advancements might positively impact financial projections amidst a backdrop of fluctuating rare earth element prices.
Over the past five years, MP Materials shareholders have seen a substantial total return of 312.72%, reflecting both share price appreciation and dividends. This long-term performance has outpaced the broader Metals and Mining industry, which saw an 8.1% return over the past year. In contrast to the short-term and industry trends, the company's recent 99% quarterly share price increase deviated from the broader market's 13% annual rise, indicating a company-specific momentum driven by strategic partnerships and expansion efforts.
Despite the recent impressive gains in share price, MP Materials is currently trading at US$24.58, placing it approximately 7.9% below the consensus analyst price target of US$26.69. As analysts have priced in future revenue and earnings growth, the ongoing developments, such as expanding production and optimizing processes, could play a crucial role in achieving these expectations. However, the narrow margin between the current price and analyst target suggests limited upside, prompting careful consideration of upcoming fiscal performance and market conditions.
Take a closer look at MP Materials' potential here in our financial health report.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NYSE:MP.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Taxes will change under Trump's ‘big, beautiful bill' — and it's a huge deal for US retirees. Here's why
President Donald Trump's so-called 'big, beautiful bill' just became law and has unleashed far-reaching impacts that both supporters and critics are scrambling to unpack. I'm 49 years old and have nothing saved for retirement — what should I do? Don't panic. Here are 6 of the easiest ways you can catch up (and fast) Thanks to Jeff Bezos, you can now become a landlord for as little as $100 — and no, you don't have to deal with tenants or fix freezers. Here's how Want an extra $1,300,000 when you retire? Dave Ramsey says this 7-step plan 'works every single time' to kill debt, get rich in America — and that 'anyone' can do it The 940-page legislative document touches on everything from immigration to healthcare, but it's the modifications to the tax code that could be most noteworthy if you're over a certain age. Here's why these new rules are a big deal for American seniors across the income spectrum, and why the next four years are a crucial window for you to adjust your tax plans accordingly. Older Americans who rely on fixed incomes and are struggling with the cost-of-living crisis can expect some financial relief from this bill's new tax credits and deductions. Those aged 65 and above can now claim an additional tax deduction of $2,000 for single filers or $1,600 for each partner filing jointly. This deduction is on top of the standard deduction that is available to all taxpayers who don't itemize their tax filings. This seniors deduction is available even to those who itemize, unlike the standard deduction. To qualify, individual taxpayers who earn up to $75,000 or couples who earn a combined income up to $150,000 can claim the full bonus deduction. The amount of deduction is gradually phased out at higher income levels and is fully phased out for anyone earning over $175,000 individually or $250,000 jointly. Besides this bonus, many seniors could also benefit from other deductions included in the bill. Auto loan borrowers, for instance, can deduct up to $10,000 in car loan interest payments if they meet certain eligibility criteria, and the amount of state and local tax (SALT) payments people can deduct from their federal taxes has been raised from $10,000 to $40,000. Altogether, many seniors, especially those with auto loans or living in high-tax states, may see a lighter tax bill as a result of this new legislation. Read more: Americans are 'revenge saving' to survive — but millions only get a measly 1% on their savings. However, it is worth noting that several of these deductions have expiry dates. The SALT deduction is set to revert to $10,000 in 2030, while the auto loan interest deduction only applies to purchases in 2025, 2026, 2027 and 2028. As for the bonus deduction for Americans ages 65 and over? That measure expires in the 2028 tax year. In other words, many of these tax relief measures are attractive but limited and temporary. Seniors who can qualify may have a short window to take advantage of these temporary benefits. Meanwhile, the One Big Beautiful Bill Act (OBBBA) makes big and permanent cuts to the social safety net, retirement benefits and medical assistance that could impact many seniors in negative ways over the long term. The OBBBA includes funding cuts for some programs and tighter eligibility rules for others that could diminish the social safety net for many seniors. Federal funding for the Supplemental Nutrition Assistance Program (SNAP), also known as food stamps, is set to be slashed and offloaded to state and local governments in October, 2027. 'To manage these new costs, states may be forced to restrict eligibility, limit benefits or withdraw from the program entirely, which would make it more difficult for eligible individuals to access food assistance,' wrote AARP chief advocacy and engagement officer Nancy LeaMond wrote in a June 29 letter to Senate leaders. 'Currently, many individuals are limited to three months of SNAP benefits every three years unless they are working for 20 hours per week or qualify for an exemption,' noted CNBC. 'The new legislation will expand those requirements to individuals ages 55 through 64, parents of minor children ages 14 and up and veterans. It is unclear when those new rules go into effect.' Over 11 million Americans over the age of 50 relied on SNAP as of 2023. Meanwhile, the more than 9 million Medicaid recipients between the ages of 50 and 64 will face new work requirements to qualify for it as a result of this legislation, according to an AARP Public Policy Institute analysis. 'This big, beautiful bill — in terms of its impact on health care, on how physicians and hospitals are going to navigate the next few years — I think is the biggest immoral piece of health care legislation I've ever seen,' Arthur L. Caplan, PhD, a professor and founding head of the division of medical ethics at NYU Grossman School of Medicine, told Healio. 'Just unethical, indefensible and tragic.' These controversial measures could be why 53% of American adults strongly or somewhat oppose of Trump's budget, according to a YouGov/Economist survey. Nevertheless, since the bill has already passed, seniors have a short window of roughly four years to take advantage of temporary tax reliefs, credits and deductions to enhance their financial security independently. Older Americans cannot afford to waste the next four years by neglecting these changes. Every dollar saved over this period could offset the long-term impacts of reduced federal support for medical and food benefits. This tiny hot Costco item has skyrocketed 74% in price in under 2 years — but now the retail giant is restricting purchases. Here's how to buy the coveted asset in bulk Here are the 6 levels of wealth for retirement-age Americans — are you near the top or bottom of the pyramid? Rich, young Americans are ditching the stormy stock market — here are the alternative assets they're banking on instead Here are 5 'must have' items that Americans (almost) always overpay for — and very quickly regret. How many are hurting you? Money doesn't have to be complicated — sign up for the free Moneywise newsletter for actionable finance tips and news you can use. This article provides information only and should not be construed as advice. It is provided without warranty of any kind. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
41 minutes ago
- Yahoo
Best Stock to Buy Right Now: Constellation Brands vs. Altria
Constellation is grappling with tariffs and weak demand. Altria is dealing with declining smoking rates. One of these blue chip giants has a brighter future. 10 stocks we like better than Constellation Brands › Constellation Brands (NYSE: STZ) and Altria (NYSE: MO) are both often considered stable blue chip stocks for income investors. Constellation is one of the world's largest producers of beers, wines, and spirits, while Altria is the largest tobacco company in America. Over the past three years, however, Constellation's stock stumbled nearly 30% as Altria's stock rallied more than 40%. Let's see why the tobacco maker outperformed the alcoholic drink maker by such a wide margin -- and if it will remain the better investment for the foreseeable future. Constellation generates most of its revenue from its beer business, which sells popular brands like Modelo, Corona, and Pacifico. A smaller percentage comes from its wine portfolio, which includes Kim Crawford, Robert Mondavi, and The Prisoner, and its spirits business, which sells Casa Noble Tequila, Svedka Vodka, and High West Whiskey. It generates nearly all of its revenue in the United States. Constellation faces three major challenges. First, its younger consumers are drinking less beer. To cope with that slowdown, Constellation is launching new types of alcoholic beverages (like hard seltzer) and alcohol-free drinks. Second, its sales of lower-end wines are declining. To offset that pressure, it divested its cheaper brands and focused on strengthening its premium brands. Lastly, the Trump administration's tariffs are driving up the costs of importing its best-selling Mexican beers. The company can offset some of that pressure by shipping more of its beers in glass bottles instead of aluminum cans (which are exposed to those higher tariffs), but an estimated 39% of its beer shipments from Mexico are still delivered in cans. It also faces production bottlenecks at its Mexican plants. Therefore, Constellation's top-line growth is being throttled by the divestments in its wine and spirits division and its softening beer sales. At the same time, the unpredictable tariffs, inflationary headwinds, and capacity constraints will continue to compress its margins. From 2024 to 2027, analysts expect Constellation's revenue to decline from $10.2 billion to $9.9 billion as it continues to right-size its business. Its earnings per share (EPS) is expected to grow at a compound annual growth rate (CAGR) of 7%. Its business certainly isn't collapsing, but its near-term headwinds and a lack of catalysts are making it an unappealing investment. The company's stock looks cheap at 14 times forward earnings, and it pays a decent forward yield of 2.5%, but its upside potential could remain limited. Altria generates most of its revenue from its flagship Marlboro cigarettes but also sells other cigarette brands, cigars, and smokeless products like e-cigarettes, snus, and nicotine pouches. It spun off its international business as Philip Morris International in 2008 and now generates nearly all of its revenue from the U.S. market. Altria's domestic concentration can be a double-edged sword. On one hand, it's well-protected from tariffs and foreign-exchange headwinds. On the other hand, adult smoking rates in the U.S. have steadily declined over the past six decades. The company counters that pressure by raising its cigarette prices to offset its declining shipments, cutting costs, and buying back a lot of shares to boost its EPS. It's also aggressively expanding its portfolio of smokeless products (especially e-cigarettes and nicotine pouches) through investments and acquisitions to curb its long-term dependence on cigarettes. In 2022, Altria's $12.8 billion investment in the e-cigarette maker Juul backfired as the Food and Drug Administration (FDA) banned all of its products. But after that big write down, it acquired Njoy, which sells FDA-approved e-cigarettes, for $2.8 billion in 2023. It expects that acquisition to start boosting EPS in 2026. From 2024 to 2027, analysts expect Altria's revenue (net of excise taxes) to dip from $20.4 billion to $20.2 billion as its core cigarette business continues to shrink. They expect its EPS to decline this year as it laps some big one-time tax benefits and the sale of its rights to Philip Morris International's Iqos heated tobacco products. But from 2025 to 2027, Altria's EPS is expected to have a steady CAGR of 5%. Its stock still looks cheap at 12 times forward earnings, and it pays a hefty forward yield of nearly 7%. Altria is a slow-growth stock, but it arguably doesn't face as many pressing issues as Constellation Brands. Constellation's business might stabilize over the next few years, but there aren't enough compelling reasons to buy its stock. Altria also faces some long-term challenges, but its business seems more stable, it pays a bigger dividend, and trades at a lower multiple. Those strengths all make Altria the better stock to buy right now. Before you buy stock in Constellation Brands, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Constellation Brands wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,432!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,005,854!* Now, it's worth noting Stock Advisor's total average return is 1,049% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of July 7, 2025 Leo Sun has positions in Altria Group. The Motley Fool recommends Constellation Brands and Philip Morris International. The Motley Fool has a disclosure policy. Best Stock to Buy Right Now: Constellation Brands vs. Altria was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Washington Post
an hour ago
- Washington Post
Why this fashionable corporate concept doesn't work
Liberal precincts of American society tried various idealistic social experiments during the past decade. Universities went 'test-optional' (on the theory that standardized testing helped the privileged), cities cut funding for police (on the theory that there were better ways to control crime), and businesses embraced 'stakeholder capitalism' (on the theory that maximizing value for shareholders was bad for society at large).
